Literature DB >> 30232646

Photobiomodulation is associated with a decrease in cell viability and migration in oral squamous cell carcinoma.

Tatiana Dias Schalch1, Maria Helena Fernandes2, Maria Fernanda Setúbal Destro Rodrigues1, Douglas Magno Guimarães3, Fabio Daumas Nunes3, João Costa Rodrigues2, Mônica Pereira Garcia1,2, Raquel Agnelli Mesquita Ferrari1, Sandra Kalil Bussadori1, Kristianne Porta Santos Fernandes4.   

Abstract

The treatment of squamous cell carcinoma (SCC) involves surgery, chemotherapy, and/or radiotherapy, which can cause mucositis (inflammation of the oral mucosa that causes considerable pain and can compromise the continuity of oncological treatment). Photobiomodulation (PBM) has been successfully used in the treatment of mucositis, but doubts arise regarding the use of laser for areas in which tumor cells may remain. In this study, the effect of PBM on the viability, mitochondrial activity, proliferation, apoptosis, and migration of cells derived from oral SCC was evaluated. SCC9 cells were irradiated with laser (660 and 780 nm, using 11 dosimetric parameters) and submitted to mitochondrial and caspase 3 activity tests after 1 and 3 days. Based on the results, cell viability (neutral red assay), proliferation (BrdU assay), and migration (scratch-wound assay) were evaluated using only the dosimetric parameters recommended for mucositis. Non-irradiated cells served as the control. The experiments were performed in triplicate. The 11 parameters diminished mitochondrial activity and induced tumor cell apoptosis. Using the parameters recommended for mucositis, irradiation with 780 nm (70 mW, 4 J/cm2) proved to be the safest and led to a reduction in cell viability, the induction of apoptosis, and a reduction in the migration capacity of the tumor cells.

Entities:  

Keywords:  Low-level laser therapy; Mouth neoplasms; Mucositis; Oral squamous carcinoma cells; Photobiomodulation

Mesh:

Substances:

Year:  2018        PMID: 30232646     DOI: 10.1007/s10103-018-2640-4

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  6 in total

1.  Could the impact of photobiomodulation on tumor response to radiation be effected by tumor heterogeneity?

Authors:  Stephen Sonis
Journal:  Support Care Cancer       Date:  2019-11-13       Impact factor: 3.603

2.  Effect of low-level light therapy before radiotherapy in oral squamous cell carcinoma: An in vitro study.

Authors:  Angeliny Tamiarana Lima Tabosa; Marcela Gonçalves Souza; Sabrina Ferreira de Jesus; Danielle Ferreira Rocha; Lorena Dos Reis Pereira Queiroz; Eloá Mangabeira Santos; Victor Hugo Dantas Guimarães; Luciano Alves de Araújo Andrade; Sérgio Henrique Santos; Alfredo Maurício Batista de Paula; Paulo Eduardo Narcizo de Souza; Lucyana Conceição Farias; André Luiz Sena Guimarães
Journal:  Lasers Med Sci       Date:  2022-08-24       Impact factor: 2.555

3.  Effects of photobiomodulation on cellular viability and cancer stem cell phenotype in oral squamous cell carcinoma.

Authors:  Ana Melissa Ccopa Ibarra; Mônica Pereira Garcia; Marlene Ferreira; Daniela de Fátima Teixeira da Silva; Christiane Pavani; Raquel Agnelli Mesquita-Ferrari; Kristianne Porta Santos Fernandes; Fabio Daumas Nunes; Maria Fernanda Setúbal Destro Rodrigues
Journal:  Lasers Med Sci       Date:  2020-08-19       Impact factor: 3.161

4.  Red Light Phototherapy Using Light-Emitting Diodes Inhibits Melanoma Proliferation and Alters Tumor Microenvironments.

Authors:  Evan Austin; Alisen Huang; Jennifer Y Wang; Marc Cohen; Edward Heilman; Emanual Maverakis; Josef Michl; Jared Jagdeo
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

5.  Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.

Authors:  Jolien Robijns; Raj G Nair; Joy Lodewijckx; Praveen Arany; Andrei Barasch; Jan M Bjordal; Paolo Bossi; Anne Chilles; Patricia M Corby; Joel B Epstein; Sharon Elad; Reza Fekrazad; Eduardo Rodrigues Fregnani; Marie-Thérèse Genot; Ana M C Ibarra; Michael R Hamblin; Vladimir Heiskanen; Ken Hu; Jean Klastersky; Rajesh Lalla; Sofia Latifian; Arun Maiya; Jeroen Mebis; Cesar A Migliorati; Dan M J Milstein; Barbara Murphy; Judith E Raber-Durlacher; Hendrik J Roseboom; Stephen Sonis; Nathaniel Treister; Yehuda Zadik; René-Jean Bensadoun
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

Review 6.  Safety and efficacy of photobiomodulation therapy in oncology: A systematic review.

Authors:  René-Jean Bensadoun; Joel B Epstein; Raj G Nair; Andrei Barasch; Judith E Raber-Durlacher; Cesar Migliorati; Marie-Thérèse Genot-Klastersky; Nathaniel Treister; Praveen Arany; Joy Lodewijckx; Jolien Robijns
Journal:  Cancer Med       Date:  2020-10-26       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.